Skip to content

Brought to you by

Dentons logo in black and white

Dentons Canada Regulatory Review

The latest information and developments on regulatory law across Canada.

open menu close menu

Dentons Canada Regulatory Review

  • Home
  • About Us
  • Dentons COVID-19 hub

Canadian securities regulators to provide blanket relief to reporting issuers with upcoming periodic filings amid the COVID-19 outbreak

By Andrea Johnson, Leanne Krawchuk, Gary Sollis, Ora Wexler, and Bennett Wong
March 23, 2020
  • COVID-19
  • Securities
Share on Facebook Share on Twitter Share via email Share on LinkedIn

The Canadian Securities Administrators (CSA) have issued a notice delivering temporary relief to reporting issuers with respect to filing deadlines in the midst of the current COVID-19 outbreak. The notice provides reporting issuers with a 45-day extension for periodic filings required on or before June 1, 2020.

The blanket relief order will apply to issuers, investment funds, registrants, some regulated entities and designated rating organizations. Filings subject to the relief extension include financial statements, management’s discussion and analysis, management reports of fund performance, annual information forms and technical reports.

Market participants relying on this exemption are not required to apply for a management cease trade order (MCTO), provided they comply with the conditions of the CSA blanket relief. In the coming days, the CSA indicates it will publish further details on this extension.

Issuers with filing deadlines after June 1, 2020, who anticipate delays due to the COVID-19 outbreak, may consider preparing for or applying for an MCTO. Issuers with filing deadlines on or prior to June 1, 2020, who expect applicable filings to be delayed beyond the 45-day relief period, should also consider whether to prepare for or apply for an MCTO. On March 16, 2020, the CSA provided an earlier notice encouraging issuers to contact their principal regulator to discuss potential impacts, and recommended that issuers consider applying for an MCTO if they anticipate not being able to file the required financial statements on time due to the outbreak.

Applications for an MCTO, which temporarily restricts management and specific insiders from trading, should ordinarily be filed at least two weeks prior to the required filing due date; however, the CSA has committed to accommodating shorter delays as necessary. An MCTO may be issued by a regulator instead of a failure-to-file cease-trade order.

As per the releases, the CSA will continue to monitor the impact of the COVID-19 outbreak and issue further guidance as needed.

If you are an issuer with questions on the CSA blanket relief, preparing an MCTO application or would like more information on other securities law matters, please contact Jessica Ward or another member of Dentons’ Securities and Corporate Finance group.

This post was originally published on dentons.com.

Share on Facebook Share on Twitter Share via email Share on LinkedIn
Subscribe and stay updated
Receive our latest blog posts by email.
Stay in Touch
Andrea Johnson

About Andrea Johnson

Andrea’s practice focuses on corporate and securities law, with an emphasis on technology and emerging growth companies. She has extensive experience in the private equity and venture capital area and has acted as lead counsel on many of the largest VC financings in Canada. Andrea also advises TSX-listed companies on IPOs, financings (including PIPEs), mergers and acquisitions, stock-based compensation and corporate governance.

All posts Full bio

Leanne Krawchuk

About Leanne Krawchuk

Leanne is a member of the Firm's Corporate group. She is also the Canada Co-chair and a global Lead for Dentons' Mining group and a member of the Dentons Canada LLP National Board and a member of the Dentons Canada LLP Audit Committee.

All posts Full bio

Gary Sollis

About Gary Sollis

Gary represents clients in the areas of corporate and securities law, with a focus on acquisitions, financings and reorganizations. He has acted for a variety of public and private companies in financing transactions, including public offerings, private placements of debt and equity, special warrant financings and public and private limited partnership offerings.

All posts Full bio

Ora Wexler

About Ora Wexler

Ora Wexler is a partner in our Corporate group and acts as Toronto office lead for the Securities group. Ora focuses her practice on a variety of public and private capital market transactions and securities regulatory matters.

All posts Full bio

Bennett Wong

About Bennett Wong

Bennett Wong is a partner in the Corporate, Securities and Corporate Finance, and Mergers and Acquisitions practice groups in Calgary. As a trusted business advisor for clients in a wide variety of sectors, including oil and gas, mining, cannabis, agribusiness, chemical, life sciences, healthcare, e-commerce, technology and real estate, Bennett is highly regarded for his pragmatic and proactive approach to bring value and results for his clients.

All posts Full bio

RELATED POSTS

  • COVID-19
  • Government Affairs
  • Health

The use of extraordinary government powers to protect public health in light of COVID-19 in Canada

By Rose M. Carter, Q.C. and Dina Awad | March 26, 2020
  • COVID-19
  • Securities

Update for Canadian public companies: Impacts of COVID-19 on earnings guidance

By Andrea Johnson and Matthew Fleming | March 17, 2020
  • COVID-19
  • Government Affairs
  • Health
  • Immigration
  • Transportation

An analysis of Canadian travel restrictions due to the COVID-19 outbreak

By Henry J. Chang and Helen Park | March 19, 2020

About Dentons

Redefining possibilities. Together, everywhere. For more information visit dentons.com

Grow, Protect, Operate, Finance. Dentons, the law firm of the future is here. Copyright 2023 Dentons. Dentons is a global legal practice providing client services worldwide through its member firms and affiliates. Please see dentons.com for Legal notices.

Categories

Dentons logo in black and white

© 2025 Dentons

  • Legal notices
  • Privacy policy
  • Terms of use
  • Cookies on this site